HRT Financial’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

HRT Financial’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-107,524	Closed	-$264K	–	4744
2026 Q1	$264K	Buy	+107,524	New	+$360K	﹤0.01%	2982
2025 Q3	–	Sell	-25,110	Closed	-$60K	–	3232
2025 Q2	$60K	Buy	25,110 +9,119	+57%	+$12.4K	﹤0.01%	2287
2025 Q1	$13K	Buy	15,991 +2,904	+22%	+$2.76K	﹤0.01%	2333
2024 Q4	$11K	Buy	+13,087	New	+$14.6K	﹤0.01%	2267
2024 Q1	–	Sell	-17,354	Closed	-$32K	–	2651
2023 Q4	$32K	Buy	+17,354	New	+$25.9K	﹤0.01%	1997
2023 Q1	–	Sell	-37,741	Closed	-$157K	–	2799
2022 Q4	$157K	Buy	+37,741	New	+$143K	﹤0.01%	1988
2022 Q3	–	Sell	-46,159	Closed	-$521K	–	3132
2022 Q2	$521K	Buy	+46,159	New	+$553K	0.01%	1442

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's NBP Position: Q2 2026 in Review

HRT Financial sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 107,524 shares — an estimated $264K sold.

HRT Financial first reported a position in NBP in Q2 2022 and held it in 7 quarters. The position peaked at $521K in Q2 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

HRT Financial reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 107,524 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $264K.
HRT Financial first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 7 quarters.
HRT Financial's NovaBridge Biosciences American Depositary Shares position peaked at $521K in Q2 2022.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.